The Turkish Version of the Vividness of Visual Imagery Questionnaire-2

Sponsor
Istanbul University-Cerrahpasa (Other)
Overall Status
Completed
CT.gov ID
NCT04335903
Collaborator
(none)
150
1
1.4
106.2

Study Details

Study Description

Brief Summary

The Vividness of Visual Imagery Questionnaire-2 (VMIQ-2) is originally developed in English to determine the vividness of visual imagery. The purpose of this study is to translate and cross-culturally adapt the VMIQ instrument into Turkish and investigate its psychometric properties.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Vividness of Visual Imagery Questionnaire-2 (VMIQ-2) was originally developed in English to determine the vividness of visual imagery. The purpose of this study is to translate and cross-culturally adapt the VMIQ-2 instrument into Turkish and investigate its psychometric properties. One hundred fifty healthy participants will be included. For cross-cultural adaptation, two bi-lingual translators will use the back-translation procedure. Within a 5-to-7-day period after the first assessment, the participants will complete the Turkish version of VMIQ (VMIQ-2-T) to evaluate test-retest reliability. Cronbach's alpha (α) will use to assess internal consistency. The correlation with the Turkish version of Kinesthetic and Visual Imagery Questionnaire-20 will be determined to check the validity.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    150 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    The Turkish Version of the Vividness of Visual Imagery Questionnaire-2
    Actual Study Start Date :
    Apr 23, 2020
    Actual Primary Completion Date :
    Jun 5, 2020
    Actual Study Completion Date :
    Jun 5, 2020

    Outcome Measures

    Primary Outcome Measures

    1. The Vividness of Visual Imagery Questionnaire-2 [Baseline (First assessment)]

      This questionnaire is composed of 12 items - walking, running, kicking a stone, bending down to pick up a coin, running up stairs, jumping sideways, throwing a stone into water, kicking a ball in the air, running downhill, riding a bike, swinging on a rope, and jumping off a high wall. It requires individuals to imagine themselves performing the 12 items, from three imagery perspectives: internal visual imagery (a first-person perspective), external visual imagery (a third-person perspective), and kinesthetic imagery (feeling the movement).

    Secondary Outcome Measures

    1. The Vividness of Visual Imagery Questionnaire-2 [Within a 5-to-7-day period after the first assessment (Second assessment)]

      This questionnaire is composed of 12 items - walking, running, kicking a stone, bending down to pick up a coin, running up stairs, jumping sideways, throwing a stone into water, kicking a ball in the air, running downhill, riding a bike, swinging on a rope, and jumping off a high wall. It requires individuals to imagine themselves performing the 12 items, from three imagery perspectives: internal visual imagery (a first-person perspective), external visual imagery (a third-person perspective), and kinesthetic imagery (feeling the movement).

    2. The Movement Imagery Questionnaire-3 [Baseline (First assessment)]

      This questionnaire is composed of 4 items and requires individuals to imagine themselves performing the 4 items, from three imagery perspectives: internal visual imagery (a first-person perspective), external visual imagery (a third-person perspective), and kinesthetic imagery (feeling the movement).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age over 18 years old

    • ability to read and write in Turkish

    • no pathology in visual ability and hearing

    • able to follow simple instructions

    Exclusion Criteria:
    • having a chronic disease

    • severe musculoskeletal, neurological or cardiovascular disorders that limit mobility

    • having any cognitive problem

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Istanbul University-Cerrahpasa Istanbul Bakırkoy Turkey 34147

    Sponsors and Collaborators

    • Istanbul University-Cerrahpasa

    Investigators

    • Principal Investigator: Tansu Birinci, MSc, Istanbul University-Cerrahpasa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tansu Birinci, PT, MSc Research Assistant, Istanbul University-Cerrahpasa
    ClinicalTrials.gov Identifier:
    NCT04335903
    Other Study ID Numbers:
    • 52025
    First Posted:
    Apr 7, 2020
    Last Update Posted:
    Jun 9, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Tansu Birinci, PT, MSc Research Assistant, Istanbul University-Cerrahpasa

    Study Results

    No Results Posted as of Jun 9, 2020